Clinical Trial: A Phase 2 Trial of the Immunogenicity and Safety of CVXGA Intranasal COVID Vaccine in Healthy Adults
Study Status: Completed
Recruit Status: RECRUITING
Condition: COVID-19
Study Type: INTERVENTIONAL
Official Title: A Phase 2 Trial of the Immunogenicity and Safety of CVXGA Intranasal COVID Vaccine in Healthy Adults
Brief Summary:
The purpose of this trial is to evaluate immunogenicity and safety of CVXGA administered as a single intranasal dose against SARS-CoV-2 S-protein in participants.The trial will enroll up to 400 healthy participants, age 18-80 years.
Read more